Seeking Alpha

Vericel Corporation (VCEL)

  • Anita Dushyanth | Send Message 27 Aug

    VCEL: Cell Therapy And Regenerative Medicine $VCEL
      • Shiraz Lakhi | Send Message 29 May

        Trading UP Today: Top 10 BIOTECH #Stocks Ranked By LOWEST Price/Sales Ratio: $VCEL $CDNA $SPPI $EBS $BOTA ++
          • Mike Zaman | Send Message 24 Mar

            Rambus (RMBS) Tech Deal With IBM; Vericel (VCEL) And Digital Ally (DGLY) Improving... $RMBS, $IBM, $VCEL
              • Jason Napodano, CFA | Send Message 6 Feb

                Why Vericel Shares Will Double In 2015 $VCEL
                  • freefdawatchlist | Send Message 11 Sep 2014

           Active on volume: $AKS, $VIAV, $LULU, $EMC, $RSH, $AAPL, $TWTR, $GPRO, $SDRL, $DGLY, $VCEL, $UVXY, $NUGT
                      • jsiebel720 | Send Message 30 Jul 2014

                        $CLBS $ATHX $STEM $BCLI $CUR $PSTI $CYTX $VCEL Must read for all those long any stem cell biotechs.
                        Reply (1)
                        • accubuff | Send Message 5 Aug 2014
                          : Thanks! Great read. Maybe I should try it on my own injury?
                          • ProspectiveProsperity | Send Message 4 Jun 2014

                            $VCEL This one has everyone talking. I like it even better at $3. Long
                              • Jerome Verony | Send Message 21 Apr 2014

                                $VCEL skyrockets on news of Sanofi cell therapy and regenerative medicine acquisition
                                  • Michael Sacerdote | Send Message 11 Apr 2014

                                    $VCEL Prediction in "Mice Scared Me Away" has been confirmed.
                                      • Jerome Verony | Send Message 9 Apr 2014

                                        $VCEL gets go ahead on phase IIb study:
                                          VCEL vs. ETF Alternatives
                                          Company Description
                                          Vericel Corpis engaged in the development of patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions. It markets two cell therapy products including Carticel and Epicel.
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States